Approved Hospital Formulary
Suggestions or Corrections? Above and Beyond Nominations Formulary Request
Show Therapeutic Classes
QR Code Add Formweb to your mobile device
Android iOS
Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.
Approved Hospital Formulary
Suggestions or Corrections? Above and Beyond Nominations Formulary Request
Search results for:

loratadine-pseudoephedrine

loratadine-pseudoephedrine
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Alavert D-12, Claritin-D 12 Hour, Loratadine-D 12 hour TABLET, EXTENDED RELEASE, ORAL 5 mg-120 mg    
Claritin-D 24 Hour TABLET, EXTENDED RELEASE, ORAL 10 mg-240 mg      
VIEW MORE Second Generation Antihistamines
Comments:

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

loratadine-pseudoephedrine (Alavert D-12, Claritin-D 12)

  • 5 mg-120 mg extended release tablet oral Q12 hours

loratadine-pseudoephedrine(Claritin-D 24 Hour)

  • 10 mg-240 mg tablet extended release oral Q24 hours
Last updated: Nov. 30, -0001






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2026 Rpharmy, LLC ­ All Rights Reserved